Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$18.65 - $26.52 $5,222 - $7,425
-280 Reduced 0.88%
31,408 $695,000
Q4 2023

Feb 13, 2024

SELL
$16.53 - $21.42 $4,297 - $5,569
-260 Reduced 0.81%
31,688 $672,000
Q3 2023

Nov 13, 2023

BUY
$20.08 - $25.39 $13,513 - $17,087
673 Added 2.15%
31,948 $643,000
Q2 2023

Aug 04, 2023

SELL
$24.77 - $29.9 $5,548 - $6,697
-224 Reduced 0.71%
31,275 $780,000
Q1 2023

May 12, 2023

BUY
$25.95 - $36.95 $3,165 - $4,507
122 Added 0.39%
31,499 $878,000
Q4 2022

Feb 10, 2023

SELL
$24.79 - $30.86 $5,825 - $7,252
-235 Reduced 0.74%
31,377 $817,000
Q3 2022

Nov 14, 2022

BUY
$24.62 - $32.44 $8,666 - $11,418
352 Added 1.13%
31,612 $821,000
Q2 2022

Aug 12, 2022

SELL
$19.74 - $29.01 $25,207 - $37,045
-1,277 Reduced 3.92%
31,260 $856,000
Q1 2022

May 13, 2022

SELL
$26.68 - $41.63 $53,039 - $82,760
-1,988 Reduced 5.76%
32,537 $868,000
Q4 2021

Feb 11, 2022

SELL
$33.67 - $43.44 $37,003 - $47,740
-1,099 Reduced 3.08%
34,525 $1.39 Million
Q3 2021

Nov 12, 2021

SELL
$30.65 - $35.68 $37,944 - $44,171
-1,238 Reduced 3.36%
35,624 $1.16 Million
Q2 2021

Aug 13, 2021

SELL
$34.33 - $44.68 $9,269 - $12,063
-270 Reduced 0.73%
36,862 $1.27 Million
Q1 2021

May 07, 2021

SELL
$40.81 - $53.88 $16,119 - $21,282
-395 Reduced 1.05%
37,132 $1.6 Million
Q4 2020

Feb 12, 2021

SELL
$36.63 - $47.63 $33,553 - $43,629
-916 Reduced 2.38%
37,527 $1.64 Million
Q3 2020

Nov 04, 2020

SELL
$30.09 - $43.02 $6,469 - $9,249
-215 Reduced 0.56%
38,443 $1.49 Million
Q2 2020

Aug 12, 2020

BUY
$27.76 - $33.42 $164,366 - $197,879
5,921 Added 18.09%
38,658 $1.25 Million
Q1 2020

May 04, 2020

SELL
$20.69 - $37.79 $33,476 - $61,144
-1,618 Reduced 4.71%
32,737 $978,000
Q4 2019

Feb 05, 2020

SELL
$32.75 - $41.43 $30,719 - $38,861
-938 Reduced 2.66%
34,355 $1.18 Million
Q3 2019

Nov 08, 2019

BUY
$33.73 - $46.27 $175,733 - $241,066
5,210 Added 17.32%
35,293 $1.19 Million
Q2 2019

Aug 13, 2019

BUY
$29.6 - $40.93 $8,524 - $11,787
288 Added 0.97%
30,083 $1.23 Million
Q1 2019

May 06, 2019

SELL
$27.85 - $38.09 $26,903 - $36,794
-966 Reduced 3.14%
29,795 $925,000
Q4 2018

Feb 13, 2019

BUY
$32.39 - $42.05 $3,239 - $4,205
100 Added 0.33%
30,761 $1.11 Million
Q3 2018

Nov 09, 2018

BUY
$35.69 - $47.65 $19,736 - $26,350
553 Added 1.84%
30,661 $1.2 Million
Q2 2018

Aug 08, 2018

BUY
$28.41 - $42.41 $163,755 - $244,451
5,764 Added 23.68%
30,108 $1.11 Million
Q1 2018

May 07, 2018

SELL
$21.18 - $33.78 $27,724 - $44,218
-1,309 Reduced 5.1%
24,344 $730,000
Q4 2017

Feb 09, 2018

BUY
$19.29 - $24.83 $2,334 - $3,004
121 Added 0.47%
25,653 $562,000
Q3 2017

Nov 09, 2017

BUY
$19.61 - $23.35 $500,682 - $596,172
25,532
25,532 $585,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.44B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.